Penthala et al., 2010 - Google Patents
Microwave assisted synthesis and in vitro cytotoxicities of substituted (Z)-2-amino-5-(1-benzyl-1H-indol-3-yl) methylene-1-methyl-1H-imidazol-4 (5H)-ones against …Penthala et al., 2010
View PDF- Document ID
- 15678179611648746385
- Author
- Penthala N
- Yerramreddy T
- Crooks P
- Publication year
- Publication venue
- Bioorganic & medicinal chemistry letters
External Links
Snippet
The synthesis of several novel substituted (Z)-2-amino-5-(1-benzyl-1H-indol-3-yl) methylene- 1-methyl-1H-imidazol-4 (5H)-ones structurally related to aplysinopsin have been carried out under microwave irradiation and conventional heating methods. The analogs 3a, 3b, 3d–3g …
- 210000004881 tumor cells 0 title abstract description 10
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cocco et al. | Synthesis and antiproliferative activity of 2, 6-dibenzylamino-3, 5-dicyanopyridines on human cancer cell lines | |
| Diana et al. | Synthesis and antitumor properties of 2, 5-bis (3′-indolyl) thiophenes: Analogues of marine alkaloid nortopsentin | |
| Abd El-Karim et al. | Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran–pyrazole derivatives as anticancer agents | |
| Diana et al. | 3, 5-Bis (3′-indolyl) pyrazoles, analogues of marine alkaloid nortopsentin: Synthesis and antitumor properties | |
| Aboraia et al. | Novel 5-(2-hydroxyphenyl)-3-substituted-2, 3-dihydro-1, 3, 4-oxadiazole-2-thione derivatives: Promising anticancer agents | |
| El-Sherief et al. | Synthesis, anticancer activity and molecular modeling studies of 1, 2, 4-triazole derivatives as EGFR inhibitors | |
| Cocco et al. | Synthesis and antitumour activity of 4-hydroxy-2-pyridone derivatives | |
| Cocco et al. | Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives | |
| Gali et al. | One-pot multicomponent synthesis of indole incorporated thiazolylcoumarins and their antibacterial, anticancer and DNA cleavage studies | |
| Kamal et al. | Synthesis and anti-cancer activity of chalcone linked imidazolones | |
| Husain et al. | Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: Design and synthesis as anticancer agents | |
| Marzouk et al. | Design and synthesis of new 1, 6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation | |
| Shaharyar et al. | Pyrazoline bearing benzimidazoles: Search for anticancer agent | |
| Abdelbaset et al. | Novel pyrrol-2 (3H)-ones and pyridazin-3 (2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors | |
| El-Gohary et al. | Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of fused [1, 3, 4] thiadiazoles | |
| Rashid et al. | Design and synthesis of pyrimidine molecules endowed with thiazolidin-4-one as new anticancer agents | |
| Kassab et al. | Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno [2, 3-d] pyrimidine derivatives | |
| Alanazi et al. | Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents | |
| Fadeyi et al. | Novel fluorinated acridone derivatives. Part 1: Synthesis and evaluation as potential anticancer agents | |
| Sharma et al. | Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids | |
| Madadi et al. | Synthesis and anti-proliferative activity of aromatic substituted 5-((1-benzyl-1H-indol-3-yl) methylene)-1, 3-dimethylpyrimidine-2, 4, 6 (1H, 3H, 5H)-trione analogs against human tumor cell lines | |
| Verma et al. | Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents | |
| Samundeeswari et al. | Design and synthesis of novel phenyl-1, 4-beta-carboline-hybrid molecules as potential anticancer agents | |
| Berest et al. | Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1, 2, 4] triazino [2, 3-c] quinazoline-6-yl) thio] acetamides | |
| Parrino et al. | Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity |